These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85. Cutaneous phaeohyphomycosis caused by Phialophora richardsiae and the effect of topical clotrimazole in its treatment. Singh SM; Agrawal A; Naidu J; de Hoog GS; Figueras MJ Antonie Van Leeuwenhoek; 1992 Jan; 61(1):51-5. PubMed ID: 1575467 [TBL] [Abstract][Full Text] [Related]
88. The association topical antifungals/topical corticosteroids in superficial mycoses of the skin: A critical review of the literature and personal experience. Veraldi S; Bortoluzzi P Dermatol Ther; 2022 Jun; 35(6):e15487. PubMed ID: 35384163 [No Abstract] [Full Text] [Related]
89. Patient practices regarding topical drugs and a 'nudge' to prevent topical steroid abuse. Barve A; Petkar S; Farande P; Patel J; Raval A Clin Exp Dermatol; 2021 Apr; 46(3):575-577. PubMed ID: 33131125 [No Abstract] [Full Text] [Related]
90. Clinical analysis of seven cases of trichloroethylene medicamentose-like dermatitis. Liu J Ind Health; 2009 Dec; 47(6):685-8. PubMed ID: 19996547 [TBL] [Abstract][Full Text] [Related]
92. Clotrimazole and Australian Prescriber. Lawrie MM Med J Aust; 1979 Dec; 2(11):606. PubMed ID: 530181 [No Abstract] [Full Text] [Related]
93. [Topical corticosteroid induced changes in the cutaneous basal lamina: scanning electron microscopy study]. Sheu HM; Yu HS Gaoxiong Yi Xue Ke Xue Za Zhi; 1986 Aug; 2(8):502-7. PubMed ID: 3482698 [No Abstract] [Full Text] [Related]
94. Unique reactions of scrotal skin to topical agents. Fisher AA Cutis; 1989 Dec; 44(6):445-7. PubMed ID: 2533058 [TBL] [Abstract][Full Text] [Related]
95. [The pharmacokinetics of oral antifungal drugs and their efficacy against cutaneous mycosis]. Sobue S; Sekiguchi K; Nabeshima T Nihon Yakurigaku Zasshi; 2005 May; 125(5):291-5. PubMed ID: 15997166 [No Abstract] [Full Text] [Related]
96. [Local combination therapy of inflammatory dermatomycosis: A review of recommendations in national and international guidelines]. Czaika VA; Zuberbier T Hautarzt; 2015 May; 66(5):360-9. PubMed ID: 25939891 [TBL] [Abstract][Full Text] [Related]
97. Cutaneous drug reaction case reports. From the world literature. Am J Clin Dermatol; 2001; 2(6):407-14. PubMed ID: 11770394 [TBL] [Abstract][Full Text] [Related]
98. [Fixed drug eruption secondary due to griseofulvin]. Diabaté A; Aka RB; Kaloga M; Vagamon B; Kourouma HS; Gue I Ann Dermatol Venereol; 2016 Mar; 143(3):223-4. PubMed ID: 26874900 [No Abstract] [Full Text] [Related]